Taltirelin

Drug profile

Key facts

Taltirelin is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including TRHR. Recorded indications include Spinocerebellar disease.

• Molecular targets: TRHR (1 listed in DrugCentral).
• Indications: Spinocerebellar disease.
• Molecular formula: C17H23N7O5; molecular weight 405.42 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Spinocerebellar disease

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Thyrotropin-releasing hormone receptor	TRHR	agonist	Ki 6.50

Chemical structure

• Molecular formula: C₁₇H₂₃N₇O₅
• Molecular weight: 405.42 g/mol
• CAS number: 103300-74-9
• InChIKey: LQZAIAZUDWIVPM-NDQFZYFBSA-N
• PubChem CID: 114750

CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCCC1C(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Taltirelin used for?

DrugCentral lists the following indications for Taltirelin: Spinocerebellar disease.

How does Taltirelin work?

Its molecular targets in DrugCentral include TRHR (agonist).

What is the chemical formula of Taltirelin?

Taltirelin has the molecular formula C17H23N7O5 and a molecular weight of 405.42 g/mol.

Sources

• DrugCentral drug card 2560 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2107016 — compound record and bioactivity
• PubChem CID 114750 — chemical identifiers
• FDA UNII DOZ62MV6A5 — substance identity
• UniProt P34981 (TRHR) — target protein

How this page is built: methodology · editorial policy & corrections.